FDA
-
-
-
-
-
-
-
Scienture to ship naloxone nasal spray to wholesalers in July
-
-
-
-
-
-
-
SCIENTURE Receives U.S. Patent Covering REZENOPY™ (Naloxone HCl) Nasal Spray 10 mg, Strengthening Intellectual Property Protection Through 2041
-
-
-
-
-
-
-
SCIENTURE receives third patent for ARBLI losartan suspension through 2041
-
-
-
-
-
-
-
SCIENTURE Reports Year End 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Scienture expects commercial launch of naloxone spray in Q2 2026
-
-
-
-
-
-
-
Scienture begins commercial sales of Arbli oral suspension
-
-
-
-
-
-
-
Scienture Holdings (SCNX) Announces Cancelation of ELOC
-
331,932 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

